XML 79 R63.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of January 20224 Bridge Loan (Details)
Jan. 16, 2024
$ / shares
Nov. 25, 2024
Jul. 15, 2024
$ / shares
Dec. 31, 2023
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Common share price       $ 0.2
Term (years)   5 years    
January 2024 Bridge Loan - Tranche #2 Warrants [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Common share price $ 2.00   $ 3.19  
Term to initial exercise date (years) [1] 6 months      
Term (years) 5 years   5 years  
January 2024 Bridge Loan - Tranche #2 Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Warrants measurement input 0   0  
January 2024 Bridge Loan - Tranche #2 Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Warrants measurement input 3.90   4.00  
January 2024 Bridge Loan - Tranche #2 Warrants [Member] | Measurement Input, Price Volatility [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Warrants measurement input 107.5   112.5  
[1] As discussed further in Note 10, the warrants were not exercisable and the exercise price was not set until certain conditions were met. As of July 15, 2024, the warrants became exercisable and no longer contain adjustment provisions to the exercise price that are not indexed to the Company’s own stock. As such, the warrants were adjusted to fair value as of the initial exercise date and then reclassified from liability classified to equity classified.